Couttas TA, Hoffmann AE, Jieu B, Golla FR, Shepherd CE, Leweke FM, Rohleder C. Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders. Transl Psychiatry. 2026 16(1)
Dammann-Bawadkji I, Leweke FM, Rohleder C. Animal Models for Drug Discovery in Schizophrenia: A Critical View from a Clinical Perspective. Pharmaceut Med. 2026 40(5):335-349. Epub 2026 Jul 14.
Hoffmann AE, Allwright M, Guennewig B, Rohleder C, Jieu B, Köthe D, Dammann I, Del Castillo AA, Mueller JK, Enning F, Shepherd CE, Couttas TA, Leweke FM. Identification of fluid endocannabinoid and sphingolipid biomarkers in schizophrenia. A machine learning approach toward clinical value. Mol Psychiatry. 2026 Oct 30. [Epub ahead of print]